# LGM Pharma Solutions, LLC - Inspection Records

Source: https://www.keypedia.com/companies/lgm-pharma-solutions-llc/5ee22c42-8e6e-4af9-a2b7-832e0d586f19

> Inspection records and compliance data for LGM Pharma Solutions, LLC in Irvine, California. Access full analysis and detailed observations.

---

## Details

- Name: LGM Pharma Solutions, LLC
- FEI Number: 3017140477
- City: Irvine
- State: California
- Country Name: United States
- Address Line 1: 17802 Gillette Ave
- Zip Code: 92614
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1232056 - LGM Pharma Solutions, LLC - 2025-01-24](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/618e10e1-dad1-4647-a441-9ddec9afd566) — source: FDA, date: January 24, 2025
- [FDA Inspection 1232056 - LGM Pharma Solutions, LLC - 2025-01-24](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/f80c6bd3-5928-4b4c-ac57-81589a52ba2a) — classification: No Action Indicated (NAI), source: FDA, date: January 24, 2025
- [483 - LGM Pharma Solutions, LLC - 2024-03-01](https://www.keypedia.com/records/483/lgm-pharma-solutions-llc/0f59dd4a-490d-41b1-a687-2ef6fdeacee1) — source: FDA, date: March 1, 2024
- [483 - LGM Pharma Solutions, LLC - 2024-03-01](https://www.keypedia.com/records/483/lgm-pharma-solutions-llc/fbc5e811-568b-41cb-9541-fed0314350c7) — source: FDA, date: March 1, 2024
- [FDA Inspection 1230374 - LGM Pharma Solutions, LLC - 2024-03-01](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/1d4efc76-d6cb-4820-a2a8-d28f1e3bc96a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 1, 2024
- [FDA Inspection 1120565 - LGM Pharma Solutions, LLC - 2020-01-31](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/959c277c-a14b-4450-8529-7d62cbe3505b) — classification: No Action Indicated (NAI), source: FDA, date: January 31, 2020
- [FDA Inspection 1062404 - LGM Pharma Solutions, LLC - 2018-08-17](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/1db1a1e8-3ccd-408e-9152-9b6bc20d6163) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2018
- [FDA Inspection 1006282 - LGM Pharma Solutions, LLC - 2017-02-13](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/86257d39-a391-41fc-886e-2c7722430735) — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2017
- [FDA Inspection 1007414 - LGM Pharma Solutions, LLC - 2016-12-13](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/aa4cce69-c65b-475b-9890-8d5d670382ae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2016
- [FDA Inspection 887244 - LGM Pharma Solutions, LLC - 2014-07-11](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/7a9a78d4-7047-4d1e-baf8-b3953e8d5fae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 11, 2014
- [FDA Inspection 776102 - LGM Pharma Solutions, LLC - 2012-04-09](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/691f6786-85aa-4e65-92d0-f64f82a18450) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 9, 2012
- [FDA Inspection 723041 - LGM Pharma Solutions, LLC - 2011-05-05](https://www.keypedia.com/records/fda_inspections/lgm-pharma-solutions-llc/648afa23-c490-465f-b465-956253c9d089) — classification: No Action Indicated (NAI), source: FDA, date: May 5, 2011

## Related Companies

- [Haleon US Inc.](https://www.keypedia.com/companies/haleon-us-inc/59f65cda-88dc-4ec6-98a9-42bd852cb203)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06)
- [AstraZeneca Pharmaceuticals, LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/ebec0358-60f4-4d3d-88a0-f03f946518ea)
- [Wyeth Farma SA](https://www.keypedia.com/companies/wyeth-farma-sa/e7e491e8-2e72-4e18-a3f3-7ae5a99e69b8)
- [Lilly France S.A.S.](https://www.keypedia.com/companies/lilly-france-sas/27fa7368-5fb0-48b1-b161-5729c7bfa061)
- [Alphapharm Pty, Ltd.](https://www.keypedia.com/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)
- [Patheon Inc.](https://www.keypedia.com/companies/patheon-inc/76561a83-edb8-4c76-934b-6b2bd5e67949)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9)
- [Takeda GmbH, Plant Oranienburg](https://www.keypedia.com/companies/takeda-gmbh-plant-oranienburg/c72ad117-1d9b-474a-8d1a-c4d0e81e9ba8)
- [MannKind Corporation](https://www.keypedia.com/companies/mannkind-corporation/b311f335-89a1-47a3-a7dc-24d2943cf1d4)

## Related Officers

- [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [Consumer Safety Officer (Inspector)](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)
- [Professor of Medicine](https://www.keypedia.com/people/lawrence-r-deyton/92881ee2-c62d-4faf-b619-4900022cc779)
- [Program Division Director](https://www.keypedia.com/people/randy-f-pack/c4e89614-5aa6-4d3f-90dc-68482b499967)